Roche Pays $220 Million For Blood Testing Innovator
Swiss pharmaceutical titan Roche Holding AG announced Tuesday that it will shell out $220 million to acquire Constitution Medical Investors Inc., which is developing a new testing system for blood diseases....To view the full article, register now.
Already a subscriber? Click here to view full article